Grant: Discovery Grants Program - Individual
Université Laval
$32,000.00
Roles of poly(ADP-ribose) polymerase-1 in mammalian transcription-coupled nucleotide excision repair of DNA damage
FY 2024-25
Summary
Roles of PARP-1 in mammalian transcription-coupled-NER (TCR) of DNA damage
Background: Nucleotide excision repair (NER) is the most versatile DNA repair pathway that removes a wide variety of lesions caused by diverse agents. There are two sub-pathways of NER: the transcription-coupled NER (TCR) rapidly removes lesions from the transcribed strand of the active genes, whereas the global genomic NER (GGR) slowly removes the lesions from rest of the genome. In this NSERC-supported program, we have previously identified two key roles of the mammalian nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP1) in GGR. Here, we will focus on its role in TCR.
Preliminary Results and Hypotheses: TCR is initiated when the transcribing RNA polymerase II (RNAPII) stalls at a DNA lesion and recruits the Cockayne syndrome B (CSB) protein to begin a multistep process to repair the damage and restart the transcription. Using various cellular TCR models, we have now observed that: (i) Impaired PARP1 sensitizes cells to DNA damage that is repaired by TCR; (ii) PARP1 interacts with RNAPII both before and after it encounters DNA damage, but it interacts with CSB only at the DNA damage; and (iii) In PARP1-impaired cells, the interaction of CSB with RNAPII, a required step to launch TCR, is significantly suppressed.
Therefore, our first hypothesis is that PARP1 present with RNAPII during normal transcription elongation, switches to a repair role when RNAPII stalls at the lesion site to facilitate efficient initiation of TCR. Our second hypothesis is that PARP1 plays a role in transcription regulation before and after TCR to facilitate lesion detection and transcription restart, respectively.
To test the hypothesis, the immediate goals are to:
1) Elucidate the role of PARP1 with the elongating RNAPII and CSB in the initiation of TCR;
2) Examine the role of PARP1 in the de novo transcription after DNA damage that plays a role in the lesion detection and in the restart of transcription after TCR.
Methods and Approaches: We have established several cellular and DNA damage models to study the TCR or GGR. The impact of PARP1 function will be examined using PARP1-gene knockout or knockdown, enzyme-dead PARP1 and PARP-inhibitors. The transcription and TCR will be monitored by Click-IT techniques for TCR-specific RNA recovery synthesis and unscheduled DNA synthesis. We will use ChIP-Seq and BrU-Seq techniques to identify global impact of PARP1 in TCR and transcription of all genes.
The long-term objective is to determine if the intervention of PARP1 in TCR is universally observed in other DNA repair pathways that remove different types of transcription-blocking lesions on the transcribed strand of genes.
Impact: Our research program aimed at identification of novel roles of PARP1 in transcription and TCR will not only advance our text-book level knowledge of these important processes but also allow better comprehension of the diseases associated with failure of TCR.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2022-05355
Name nom
Shah, Girish
Department département
Biologie moléculaire, biochimie médicale et pathologie - Biologie moléculaire, biochimie médicale et pathologie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5302
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene expression
Research subject fr
Expression génétique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Roles of poly(ADP-ribose) polymerase-1 in mammalian transcription-coupled nucleotide excision repair of DNA damage
Keywords
parp1: poly(adp-ribose)polymerase-1; dna damage; dna repair; ner: nucleotide excision repair; transcription-coupled ner; parp1-knockkout-knockdown; protein recruitment; chromatin remodelling; transcription-de novo, arrest and restart; unscheduled dna synthesis
Application summary
Roles of PARP-1 in mammalian transcription-coupled-NER (TCR) of DNA damage
Background: Nucleotide excision repair (NER) is the most versatile DNA repair pathway that removes a wide variety of lesions caused by diverse agents. There are two sub-pathways of NER: the transcription-coupled NER (TCR) rapidly removes lesions from the transcribed strand of the active genes, whereas the global genomic NER (GGR) slowly removes the lesions from rest of the genome. In this NSERC-supported program, we have previously identified two key roles of the mammalian nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP1) in GGR. Here, we will focus on its role in TCR.
Preliminary Results and Hypotheses: TCR is initiated when the transcribing RNA polymerase II (RNAPII) stalls at a DNA lesion and recruits the Cockayne syndrome B (CSB) protein to begin a multistep process to repair the damage and restart the transcription. Using various cellular TCR models, we have now observed that: (i) Impaired PARP1 sensitizes cells to DNA damage that is repaired by TCR; (ii) PARP1 interacts with RNAPII both before and after it encounters DNA damage, but it interacts with CSB only at the DNA damage; and (iii) In PARP1-impaired cells, the interaction of CSB with RNAPII, a required step to launch TCR, is significantly suppressed.
Therefore, our first hypothesis is that PARP1 present with RNAPII during normal transcription elongation, switches to a repair role when RNAPII stalls at the lesion site to facilitate efficient initiation of TCR. Our second hypothesis is that PARP1 plays a role in transcription regulation before and after TCR to facilitate lesion detection and transcription restart, respectively.
To test the hypothesis, the immediate goals are to:
1) Elucidate the role of PARP1 with the elongating RNAPII and CSB in the initiation of TCR;
2) Examine the role of PARP1 in the de novo transcription after DNA damage that plays a role in the lesion detection and in the restart of transcription after TCR.
Methods and Approaches: We have established several cellular and DNA damage models to study the TCR or GGR. The impact of PARP1 function will be examined using PARP1-gene knockout or knockdown, enzyme-dead PARP1 and PARP-inhibitors. The transcription and TCR will be monitored by Click-IT techniques for TCR-specific RNA recovery synthesis and unscheduled DNA synthesis. We will use ChIP-Seq and BrU-Seq techniques to identify global impact of PARP1 in TCR and transcription of all genes.
The long-term objective is to determine if the intervention of PARP1 in TCR is universally observed in other DNA repair pathways that remove different types of transcription-blocking lesions on the transcribed strand of genes.
Impact: Our research program aimed at identification of novel roles of PARP1 in transcription and TCR will not only advance our text-book level knowledge of these important processes but also allow better comprehension of the diseases associated with failure of TCR.